115.27
price up icon0.93%   +1.06
after-market  After Hours:  114.90  -0.37   -0.32%
loading
Albemarle Corp. stock is currently priced at $115.27, with a 24-hour trading volume of 2.05M. It has seen a +0.93% increased in the last 24 hours and a -4.63% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $113.5 pivot point. If it approaches the $116.7 resistance level, significant changes may occur.
Previous Close:
$114.21
Open:
$114.3
24h Volume:
2.05M
Market Cap:
$13.55B
Revenue:
$9.62B
Net Income/Loss:
$1.57B
P/E Ratio:
4.0876
EPS:
28.2
Net Cash Flow:
$-823.96M
1W Performance:
+0.77%
1M Performance:
-4.63%
6M Performance:
-17.21%
1Y Performance:
-37.34%
1D Range:
Value
$112.18
$115.73
52W Range:
Value
$106.69
$247.44

Albemarle Corp. Stock (ALB) Company Profile

Name
Name
Albemarle Corp.
Name
Phone
980-299-5700
Name
Address
4350 Congress Street, Suite 700, Charlotte, NC
Name
Employee
5,400
Name
Twitter
@AlbemarleCorp
Name
Next Earnings Date
2024-05-02
Name
Latest SEC Filings
Name
ALB's Discussions on Twitter

Albemarle Corp. Stock (ALB) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-09-24 Downgrade Citigroup Buy → Neutral
Jan-29-24 Downgrade TD Cowen Outperform → Market Perform
Jan-11-24 Downgrade Deutsche Bank Buy → Hold
Dec-12-23 Upgrade BofA Securities Underperform → Neutral
Dec-05-23 Downgrade Piper Sandler Neutral → Underweight
Nov-29-23 Resumed JP Morgan Neutral
Nov-06-23 Downgrade UBS Buy → Neutral
Oct-25-23 Downgrade Piper Sandler Overweight → Neutral
Oct-18-23 Downgrade BofA Securities Neutral → Underperform
Jun-14-23 Initiated Citigroup Buy
May-18-23 Upgrade UBS Neutral → Buy
May-15-23 Upgrade Robert W. Baird Neutral → Outperform
May-11-23 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
May-09-23 Upgrade Scotiabank Sector Perform → Sector Outperform
May-08-23 Upgrade BofA Securities Underperform → Neutral
Apr-05-23 Downgrade BofA Securities Neutral → Underperform
Jan-31-23 Reiterated Credit Suisse Underperform
Jan-26-23 Initiated Piper Sandler Overweight
Jan-04-23 Upgrade Vertical Research Hold → Buy
Oct-13-22 Downgrade Berenberg Buy → Hold
Jul-20-22 Upgrade KeyBanc Capital Markets Underweight → Sector Weight
Jun-27-22 Initiated Credit Suisse Underperform
Jun-02-22 Downgrade UBS Buy → Neutral
May-12-22 Upgrade Wells Fargo Equal Weight → Overweight
Feb-01-22 Upgrade BofA Securities Underperform → Neutral
Jan-27-22 Upgrade HSBC Securities Hold → Buy
Dec-15-21 Downgrade Goldman Neutral → Sell
Oct-19-21 Upgrade RBC Capital Mkts Sector Perform → Outperform
Oct-13-21 Initiated Mizuho Neutral
Sep-08-21 Upgrade Berenberg Sell → Buy
Aug-06-21 Reiterated BofA Securities Underperform
Aug-06-21 Reiterated Deutsche Bank Buy
Aug-06-21 Reiterated KeyBanc Capital Markets Underweight
Aug-06-21 Reiterated Wells Fargo Equal Weight
May-13-21 Upgrade RBC Capital Mkts Underperform → Sector Perform
May-07-21 Upgrade JP Morgan Underweight → Neutral
Apr-19-21 Upgrade Evercore ISI In-line → Outperform
Mar-10-21 Initiated Cowen Outperform
Mar-01-21 Upgrade Loop Capital Hold → Buy
Feb-22-21 Upgrade Vertical Research Sell → Hold
Feb-16-21 Upgrade Deutsche Bank Hold → Buy
Feb-12-21 Upgrade Citigroup Neutral → Buy
Jan-06-21 Downgrade Citigroup Buy → Neutral
Jan-05-21 Upgrade Evercore ISI Underperform → In-line
Jan-05-21 Downgrade Vertical Research Buy → Sell
Nov-09-20 Upgrade Citigroup Neutral → Buy
Oct-21-20 Upgrade HSBC Securities Hold → Buy
Oct-14-20 Downgrade RBC Capital Mkts Sector Perform → Underperform
Sep-29-20 Upgrade Vertical Research Hold → Buy
Sep-22-20 Initiated Evercore ISI Underperform
Jul-27-20 Downgrade Berenberg Hold → Sell
Jun-26-20 Upgrade Loop Capital Sell → Hold
Jun-22-20 Downgrade KeyBanc Capital Markets Sector Weight → Underweight
May-12-20 Downgrade Goldman Buy → Neutral
Apr-29-20 Downgrade Loop Capital Buy → Sell
Mar-26-20 Initiated KeyBanc Capital Markets Sector Weight
Feb-21-20 Downgrade Vertical Research Buy → Hold
Feb-05-20 Downgrade Robert W. Baird Outperform → Neutral
Jan-22-20 Downgrade HSBC Securities Buy → Hold
Nov-14-19 Downgrade Seaport Global Securities Buy → Neutral
Nov-13-19 Downgrade Citigroup Neutral → Sell
Nov-12-19 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-08-19 Downgrade JP Morgan Neutral → Underweight
Oct-28-19 Downgrade BofA/Merrill Buy → Underperform
Oct-25-19 Downgrade SunTrust Buy → Hold
View All

Albemarle Corp. Stock (ALB) Financials Data

Albemarle Corp. (ALB) Revenue 2024

ALB reported a revenue (TTM) of $9.62 billion for the quarter ending December 31, 2023, a +31.38% rise year-over-year.
loading

Albemarle Corp. (ALB) Net Income 2024

ALB net income (TTM) was $1.57 billion for the quarter ending December 31, 2023, a -41.50% decrease year-over-year.
loading

Albemarle Corp. (ALB) Cash Flow 2024

ALB recorded a free cash flow (TTM) of -$823.96 million for the quarter ending December 31, 2023, a -227.51% decrease year-over-year.
loading

Albemarle Corp. (ALB) Earnings per Share 2024

ALB earnings per share (TTM) was $13.34 for the quarter ending December 31, 2023, a -41.54% decline year-over-year.
loading

Albemarle Corp. Stock (ALB) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Johnson Netha N.
President, Specialties
Feb 28 '24
Option Exercise
0.00
1,680
0
32,163
Norris Eric
President, Energy Storage
Feb 28 '24
Option Exercise
0.00
1,680
0
35,585
Barichivich John Clarence III
VP, Controller & CAO
Feb 28 '24
Option Exercise
0.00
535
0
6,375
Fourie Jacobus G.
Chief Capital Projects Officer
Feb 28 '24
Option Exercise
0.00
917
0
16,923
Anderson Melissa H.
EVP, Chief People Officer
Feb 26 '24
Option Exercise
0.00
597
0
4,454
Barichivich John Clarence III
VP, Controller & CAO
Feb 26 '24
Option Exercise
0.00
279
0
5,922
Norris Eric
President, Energy Storage
Feb 26 '24
Option Exercise
0.00
875
0
34,292
Barichivich John Clarence III
VP, Controller & CAO
Feb 22 '24
Option Exercise
0.00
280
0
5,725
Anderson Melissa H.
EVP, Chief People Officer
Feb 22 '24
Option Exercise
0.00
1,194
0
3,426
Johnson Netha N.
President, Specialties
Feb 22 '24
Option Exercise
0.00
1,750
0
30,060
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. Its Lithium and Advanced Materials segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties, as well as reagents, such as butyllithium and lithium aluminum hydride for applications in lithium batteries for consumer electronics and automobiles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes, life science, pharmaceutical, and other markets. It also offers cesium products for the chemical and pharmaceutical markets; zirconium, barium, and titanium products for various pyrotechnical applications; technical services, such as the handling and use of reactive lithium products; and recycling services for lithium-containing by-products. In addition, this segment offers performance catalyst solutions comprising organometallics, polymer catalysts, and curatives for polyolefin polymers, packaging, non-packaging, films, injection molding, alpha-olefins, polyurethanes, epoxies, and engineered resins markets. Its Bromine Specialties segment offers bromine and bromine-based solutions for fire safety, chemical synthesis, mercury control, water purification, beef and poultry processing, and other industrial applications, as well as oil and gas well drilling, and completion fluids applications; and tertiary amines, biocides, disinfectants, and sanitizers. Its Refining Solutions segment offers clean fuels technologies, which is primarily composed of hydroprocessing catalysts; and fluidized catalytic cracking catalysts and additives for refining industry. It serves energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. The company was founded in 1994 and is headquartered in Charlotte, North Carolina.
$25.46
price down icon 0.74%
specialty_chemicals WLK
$149.90
price up icon 0.36%
specialty_chemicals IFF
$85.14
price down icon 0.34%
specialty_chemicals PPG
$130.52
price up icon 0.07%
specialty_chemicals DD
$73.96
price up icon 0.22%
specialty_chemicals LYB
$100.78
price up icon 0.23%
Cap:     |  Volume (24h):